Information Provided By:
Fly News Breaks for September 6, 2016
DVA
Sep 6, 2016 | 07:17 EDT
BofA/Merrill downgraded DaVita (DVA) to Neutral and lowered its price target to $70 saying growth rates are likely to remain muted. The firm's analyst said poor performance at HCP, Inc (HCP) is unlikely to improve in 2017 and tail risk scenarios on a CMS decision could be bigger than expected on the dialysis business.
News For DVA From the Last 2 Days
There are no results for your query DVA